↑ Rising
Business
U.S. court orders Guardant to pay $245 million in DNA sequencing patent dispute
A U.S. court has ordered Guardant Health to pay $245 million following a legal defeat in a DNA sequencing patent dispute.
Dna Sequencing
1 trends tracked about this subject — the full history, oldest to newest below.